Altered immune system in frailty: Genetics and diet may influence inflammation.


Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
09 2019
Historique:
received: 22 12 2018
revised: 11 07 2019
accepted: 15 07 2019
pubmed: 22 7 2019
medline: 1 5 2020
entrez: 22 7 2019
Statut: ppublish

Résumé

Frailty is a complex geriatric syndrome associated with biological vulnerability to stressors and decreased physiological reserve. Its etiology and pathogenesis are not completely understood, although various causes and complex pathways have been proposed. Immune system alterations (immunosenescence and "InflammAging") have been suggested to contribute to frailty, but a precise causative role of such alterations remains to be determined. Genetic studies support the suggestion of immune system involvement in frailty: genetic variants in genes involved in immune system function have been associated with the syndrome. Interestingly, nutritional status, through its effects on cellular metabolism, may also influence the immune system, i.e. hormone and cytokine (mainly adipocytokine) levels, and immune cell populations and function, increasing inflammation and contributing to frailty. This review aims to discuss the role of immune system alterations in frailty, analyzing the role of genetic factors in frailty onset and the impact of diet on inflammation and, in turn, on frailty.

Identifiants

pubmed: 31326616
pii: S1568-1637(18)30342-8
doi: 10.1016/j.arr.2019.100935
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100935

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Orietta Pansarasa (O)

Genomic and post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy. Electronic address: orietta.pansarasa@mondino.it.

Cristiana Pistono (C)

Golgi Cenci Foundation, Abbiategrasso, Milan, Italy.

Annalisa Davin (A)

Golgi Cenci Foundation, Abbiategrasso, Milan, Italy.

Matteo Bordoni (M)

Genomic and post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy.

Maria Chiara Mimmi (MC)

Genomic and post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy; Golgi Cenci Foundation, Abbiategrasso, Milan, Italy.

Antonio Guaita (A)

Golgi Cenci Foundation, Abbiategrasso, Milan, Italy.

Cristina Cereda (C)

Genomic and post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH